Targeting glioblastoma signaling and metabolism with a re-purposed brain-penetrant drug

Targeting glioblastoma signaling and metabolism with a re-purposed brain-penetrant drug

Summary: The highly lethal brain cancer glioblastoma (GBM) poses a daunting challenge because the blood-brain barrier renders potentially druggable amplified or mutated oncoproteins relatively inaccessible. Here, we identify sphingomyelin phosphodiesterase 1 (SMPD1), an enzyme that regulates the con...

Full description

Saved in:
Bibliographic Details
Main Authors: Junfeng Bi, Atif Khan, Jun Tang, Aaron M. Armando, Sihan Wu, Wei Zhang, Ryan C. Gimple, Alex Reed, Hui Jing, Tomoyuki Koga, Ivy Tsz-Lo Wong, Yuchao Gu, Shunichiro Miki, Huijun Yang, Briana Prager, Ellis J. Curtis, Derek A. Wainwright, Frank B. Furnari, Jeremy N. Rich, Timothy F. Cloughesy, Harley I. Kornblum, Oswald Quehenberger, Andrey Rzhetsky, Benjamin F. Cravatt, Paul S. Mischel
Format: article
Language:EN
Published: Elsevier 2021
Subjects:
glioblastoma
sphingolipid metabolism
SMPD1
fluoxetine
Membrane lipids
EGFR signaling
Biology (General)
QH301-705.5
Online Access:https://doaj.org/article/8516b7196aa84c49af33aefb9f94a103
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/8516b7196aa84c49af33aefb9f94a103

Similar Items